In the current study, we demonstrate that HELLS inhibits cervical cancer cells ferroptosis by promoting NRF2 expression, as evidenced by: (1) HELLS was upregulated in cervical carcinoma. This evidence concerns the gene HELLS and cervical carcinoma.